Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

NeoGenomics, Inc. (NEO) had Revenue of $591.64M for the most recently reported fiscal year, ending 2023-12-31.

Quarterly Annual

Figures for fiscal year ending 2023-12-31

Income Statement Financials
Revenue	$591.64M
Net Income	$-87.97M
Cost of Goods Sold	$347.04M
Gross Profit	$244.60M
Operating Expenses	$699.38M
Operating Income	$-107.74M
Non-Operating Income/Expense	$10.64M
Pre-Tax Income	$-97.10M
Normalized Pre-Tax Income	$-97.10M
Income after Taxes	$-87.97M
Income from Continuous Operations	$-87.97M
Consolidated Net Income/Loss	$-87.97M
Normalized Income after Taxes	$-87.97M
EBIT	$-107.74M
EBITDA	$-32.28M
Weighted-Average Shares Outstanding (Basic)	125.50M
Weighted-Average Shares Outstanding (Diluted)	125.50M
Earnings per Share (EPS) (Basic)	$-0.70
Earnings per Share (EPS) (Diluted)	$-0.70
Balance Sheet Financials
Current Assets	$596.81M
Property, Plant, and Equipment	$92.01M
Long-Term Assets	$1.08B
Total Assets	$1.68B
Current Liabilities	$96.30M
Long-Term Debt	$538.20M
Long-Term Liabilities	$643.39M
Total Liabilities	$739.69M
Common Equity	$941.54M
Tangible Shareholders Equity	$45.64M
Shareholders Equity	$941.54M
Common Shares Outstanding	127.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.95M
Cash Flow from Investing Activities	$76.71M
Cash Flow from Financial Activities	$4.55M
Beginning Cash	$263.18M
End Cash	$342.49M
Increase/Decrease in Cash	$79.31M
Stock-Based Compensation	$24.63M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	6.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.57
Gross Margin	41.34%
Operating Margin	-18.21%
EBIT Margin	-18.21%
EBITDA Margin	-5.46%
Pre-Tax Profit Margin	-16.41%
Profit Margin	-14.87%
Free Cash Flow	$-30.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	14.37
Receiveable Turnover	4.51
Days Sales in Receivables	80.96
Return on Equity	-9.34%
Return on Tangible Equity	-192.73%
Return on Assets	-5.23%
Return on Investments	-5.94%
Book Value Per Share	$7.39
Free Cash Flow per Share	$-0.24
Operating Cash Flow per Share	$-0.02

Data from Zacks Investment Research, Inc.